Search Results 1821-1830 of 19554 for hemoglobin

1. Vinorelbine Tartrate and Cyclophosphamide in Combination with Bevacizumab or Temsirolimus in Treating Patients with Recurrent or Refractory Rhabdomyosarcoma - Mayo Clinic

   Hemoglobin ≥ 8.0 g/dL (may receive packed red blood cells [PRBC] transfusions); Bone marrow disease involvement of tumor is allowed, however, peripheral ...

2. A Study to Evaluate the Safety and Effectiveness of Obeticholic Acid Treatment on People with Non-Alcoholic Steatohepatitis with Fibrosis - Mayo Clinic

   Type 2 diabetes diagnosed per 2013 American Diabetes Association criteria (hemoglobin A1c [HbA1c] ≥ 6.5%, fasting plasma glucose ≥ 126 mg/dL, 2-hour ...

3. A Phase 3, randomized, open-label, controlled study comparing the efficacy and safety of zanidatamab to trastuzumab, each in combination with physician’s choice chemotherapy, for the treatment of participants with metastatic HER2-positive breast cancer - Mayo Clinic

   Hemoglobin ≥ 8 g/dL; participants with chronic anemia (other than autoimmune hemolytic anemia) that is supported by intermittent red blood cell ...

4. A Study Comparing Ibrutinib and Obinutuzumab With or Without Venetoclax in Treating Patients with Chronic Lymphocytic Leukemia - Mayo Clinic

   Evidence of progressive marrow failure as manifested by the development of worsening anemia (hemoglobin [Hg] < 11 g/dl) and/or thrombocytopenia (platelets < 100 ...

5. Study of BLU-667 in Patients with Thyroid Cancer, Non-Small Cell Lung Cancer (NSCLC) and Other Advanced Solid Tumors - Mayo Clinic

   Hemoglobin < 9.0 g/dL (red blood cell transfusion and erythropoietin may be used to reach at least 9.0 g/dL, but must have been administered at least 2 ...

6. Lower or Standard Dose Regorafenib in Treating Patients With Refractory Metastatic Colorectal Cancer - Mayo Clinic

   Platelet count > 100,000/mm^3; Hemoglobin > 9.0 g/dL; Total bilirubin ≤ 1.5 x upper limit of normal (ULN); Alanine aminotransferase (ALT) and aspartate amino ...

7. Pilot Study Of Duodenal Mucosal RF Vapor Ablation In US Subjects With Type-2 Diabetes Mellitus - Mayo Clinic

   Persistent anemia, defined as hemoglobin <10g/dl. Significant cardiovascular disease, including known history of valvular disease, or myocardial infarction ...

8. A Study Evaluating AMG 424 in Subjects With Multiple Myeloma - Mayo Clinic

   Hemoglobin > 8.0 g/dL (> 80 g/L). Use of erythropoietic stimulating factors and red blood cell (RBC) transfusions per institutional guidelines is allowed ...

9. T-DM1 and Tucatinib Compared With T-DM1 Alone in Preventing Relapses in People With High Risk HER2-Positive Breast Cancer - Mayo Clinic

   - Hemoglobin >= 8 g/dL (Note: packed red blood cells [PRBC] transfusion is not permitted to achieve eligibility) - Platelet count >= 100,000/mm^3 - ...

10. Gemcitabine Plus Cisplatin With or Without Bintrafusp Alfa (M7824) in Participants With 1L Biliary Tract Cancer (BTC) - Mayo Clinic

    ... hemoglobin (Hgb) ≥ 9 g/dL (participants may have been transfused) at study entry and at Week 1 Day 1 prior to dosing. Previously transfused participants ...